ArticleBioengineering (Basel, Switzerland)2025
Evaluation of Parkinson's Disease Motor Symptoms via Wearable Inertial Measurements Units and Surface Electromyography Sensors.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Wearable Electromyography and Inertial Sensor Phenotypes Across Clinical Subtypes of Parkinson's Disease.Neurology and therapy · 2026Article
- Multi-Task Wearable Parkinson's Disease Detection with a Pretrained Spatio-Temporal Graph Encoder and Task-Level Token Aggregation.Bioengineering (Basel, Switzerland) · 2026Article
- AI-Enabled Flexible Sensing Ecosystems for Parkinson's Disease: Advancing Digital Biomarkers and Closed-Loop Interventions.Sensors (Basel, Switzerland) · 2026Review
- Multimodal machine learning mobility assessment in Parkinson's disease within supervised and unsupervised settings.Journal of neuroengineering and rehabilitation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Parkinson's disease (PD) is one of the fastest-growing neurodegenerative disorders; its cardinal motor signs-tremor, bradykinesia, and rigidity-substantially impair quality of life. Conventional clinician-rated scales can be subjective and exhibit limited interrater reliability, underscoring the need for objective and reliable quantification. We present an integrated evaluation framework that leverages surface electromyography (sEMG) with multimodal sensing. For representation learning, we combine time-frequency descriptors with Mini-ROCKET features. Grading is performed by an sEMG-based Unified Parkinson's Disease Rating Scale (UPDRS) model (LDA-SV) that produces per-segment probabilities for ordinal scores (0-3) and aggregates them via soft voting to assign item-level ratings. Participants completed a standardized protocol spanning gait, seated rest, and upper-limb tasks (forearm pronation-supination, finger-to-nose, fist clench, and thumb-index pinch). Using the aforementioned dataset, we report task-wise performance with 95% confidence intervals and compare the proposed model against CNN, LSTM, and InceptionTime using McNemar tests and log-odds ratios. The results indicate that the proposed model outperforms the three baseline models overall. These findings demonstrate the effectiveness and feasibility of the proposed approach, suggesting a viable pathway for the objective quantification of PD motor symptoms and facilitating broader clinical adoption of sEMG in diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.